Ensemtx
Founded 2021 · 20 employees on LinkedIn · 1 known investors
ENSEM Therapeutics develops small molecule precision medicines for oncology using its Kinetic Ensemble platform, which combines computational and AI/deep learning methods with experimental techniques to identify cryptic binding pockets. The company focuses on structure-based drug design for high-value, difficult-to-drug targets.
Investors · 1
Frequently asked questions
- What does Ensemtx do?
- ENSEM Therapeutics develops small molecule precision medicines for oncology using its Kinetic Ensemble platform, which combines computational and AI/deep learning methods with experimental techniques to identify cryptic binding pockets. The company focuses on structure-based drug design for high-value, difficult-to-drug targets.
- Who are Ensemtx's investors?
- Ensemtx's investors include Cenova Capital.